Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Johnson

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
AIDS and Behavior|June 23, 2025
Randomized Controlled Trial of a Couples-Based HIV Intervention for Transgender Women and Their Partners: Findings from the "It Takes Two" ProjectKristi E Gamarel, Don Operario, Ellen S Stein, et al.
International Journal of Antimicrobial Agents|October 26, 2005
Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)George G Zhanel, Tamiko L Hisanaga, Nancy M Laing, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)George G Zhanel, Melanie DeCorby, Heather Adam, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006George G Zhanel, Mel DeCorby, Nancy Laing, et al.
Molecular Genetics and Metabolism|May 26, 2023
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry communityChristoph Wanner, Alberto Ortiz, William R Wilcox, et al.
Journal of the Association of Genetic Technologists|December 9, 2020
Genetic Variants in Host Protein Disulfide Isomerase 2 (PDIA2) are Associated with Susceptibility to Chlamydia Trachomatis InfectionChristopher Zysk, Steven Williams, Itzel Chavarria, et al.
BMJ Open|October 11, 2020
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiativeDerralynn A Hughes, Patricio Aguiar, Patrick B Deegan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 27, 2021
Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosisAmanda Bevan, Zhe Hui Hoo, Nikki Totton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2022
Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331]Amanda Bevan, Zhe Hui Hoo, Nikki Totton, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
AIDS and Behavior|June 23, 2025
Randomized Controlled Trial of a Couples-Based HIV Intervention for Transgender Women and Their Partners: Findings from the "It Takes Two" ProjectKristi E Gamarel, Don Operario, Ellen S Stein, et al.
International Journal of Antimicrobial Agents|October 26, 2005
Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)George G Zhanel, Tamiko L Hisanaga, Nancy M Laing, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)George G Zhanel, Melanie DeCorby, Heather Adam, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006George G Zhanel, Mel DeCorby, Nancy Laing, et al.
Molecular Genetics and Metabolism|May 26, 2023
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry communityChristoph Wanner, Alberto Ortiz, William R Wilcox, et al.
Journal of the Association of Genetic Technologists|December 9, 2020
Genetic Variants in Host Protein Disulfide Isomerase 2 (PDIA2) are Associated with Susceptibility to Chlamydia Trachomatis InfectionChristopher Zysk, Steven Williams, Itzel Chavarria, et al.
BMJ Open|October 11, 2020
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiativeDerralynn A Hughes, Patricio Aguiar, Patrick B Deegan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 27, 2021
Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosisAmanda Bevan, Zhe Hui Hoo, Nikki Totton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2022
Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331]Amanda Bevan, Zhe Hui Hoo, Nikki Totton, et al.
Pageof 3